QingSong Health (HKG:2661) said the stabilization period for its global offering ended on Jan. 17, with no stabilizing action taken and the overallotment option lapsing unexercised, according to a Sunday Hong Kong bourse filing.
The company said there was no over-allocation in the international offering and no shares were issued under the over-allotment option.
QingSong Health added that it continues to comply with Hong Kong listing rules on public float, with at least 25% of its issued shares held by the public.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments